New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
MannKind Corporation (MNKD) vs Ocular Therapeutix, Inc. (OCUL)
- MannKind Corporation MNKD 3.91 −0.76%
- Ocular Therapeutix, Inc. OCUL 5.70 −2.73%
MannKind Corporation and Ocular Therapeutix, Inc. are both Biotechnology companies. MannKind Corporation and Ocular Therapeutix, Inc. are of similar size ($1.4B and $1.3B). MannKind Corporation grew revenue faster over the last twelve months: 31.7% against −9.68%. MannKind Corporation has the higher net margin (−18.1% vs −648.6%) and the lower return on invested capital (−2.58% vs 0.00%). Across the 17 metrics below, MannKind Corporation leads on 12 and Ocular Therapeutix, Inc. on 5.
Valuation
Profitability
| Metric | MNKD | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.76% | 87.32% | 70.18% |
| Operating margin | (2.88%) | (680.91%) | 0.00% |
| Net margin | (18.10%) | (648.64%) | 0.00% |
| Free cash flow margin | (18.97%) | (530.00%) | 0.00% |
| Return on equity | 182.90% | (93.48%) | (51.58%) |
| Return on assets | (12.29%) | (64.30%) | (45.91%) |
| Return on invested capital | (2.58%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack